PepsiCo Work in process increased by 14.1% to $154.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $131.00M to $154.00M. Over 4 years (FY 2020 to FY 2024), Work in process shows a downward trend with a -15.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $381.00M | $178.00M | $151.00M | $154.00M | $158.00M | $150.00M | $114.00M | $115.00M | $110.00M | $119.00M | $104.00M | $97.00M | $121.00M | $131.00M | $104.00M | $118.00M | $135.00M | $154.00M |
| QoQ Change | — | -53.3% | -15.2% | +2.0% | +2.6% | -5.1% | -24.0% | +0.9% | -4.3% | +8.2% | -12.6% | -6.7% | +24.7% | +8.3% | -20.6% | +13.5% | +14.4% | +14.1% |
| YoY Change | — | — | — | — | -58.5% | -15.7% | -24.5% | -25.3% | -30.4% | -20.7% | -8.8% | -15.7% | +10.0% | +10.1% | +0.0% | +21.6% | +11.6% | +17.6% |
| % of Inventories | 7.6% | 4.1% | 3.5% | 3.2% | 3.0% | 3.0% | 2.2% | 2.0% | 1.8% | 2.1% | 1.9% | 1.7% | 2.1% | 2.3% | 2.0% | 2.1% | 2.1% | 2.5% |
| Share Change | — | -3.5pp | -0.6pp | -0.2pp | -0.2pp | +0.0pp | -0.8pp | -0.2pp | -0.2pp | +0.3pp | -0.2pp | -0.2pp | +0.3pp | +0.3pp | -0.4pp | +0.1pp | -0.0pp | +0.4pp |
We use cookies for analytics. See our Privacy and Cookie Policy.